Daxor Corporation (NASDAQ:DXR) Sees Large Growth in Short Interest

Posted by Brian Himes on Jun 1st, 2026

Daxor Corporation (NASDAQ:DXR – Get Free Report) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totaling 9,066 shares, an increase of 155.1% from the April 30th total of 3,554 shares. Based on an average daily volume of 12,397 shares, the short-interest ratio is presently 0.7 days. Currently, 0.4% of the shares of the stock are sold short.

Institutional Investors Weigh In On Daxor

Several large investors have recently bought and sold shares of the company. Aristides Capital LLC acquired a new position in shares of Daxor during the 1st quarter worth approximately $403,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Daxor during the 1st quarter worth approximately $245,000. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Daxor during the 4th quarter worth approximately $184,000. Crescent Grove Advisors LLC acquired a new position in shares of Daxor during the 1st quarter worth approximately $104,000. Finally, Osaic Holdings Inc. acquired a new position in shares of Daxor during the 2nd quarter worth approximately $86,000. 1.34% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Lake Street Capital assumed coverage on Daxor in a research note on Wednesday, February 11th. They issued a “buy” rating for the company. Weiss Ratings restated a “hold (c)” rating on shares of Daxor in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy”.

Check Out Our Latest Report on DXR

Daxor Price Performance

Shares of Daxor stock traded down $0.34 on Monday, hitting $9.94. The company’s stock had a trading volume of 478 shares, compared to its average volume of 9,411. Daxor has a 1 year low of $8.08 and a 1 year high of $14.76. The firm has a fifty day moving average price of $10.20 and a 200-day moving average price of $11.86.

Daxor (NASDAQ:DXR – Get Free Report) last posted its quarterly earnings data on Monday, March 2nd. The company reported ($0.10) EPS for the quarter.

Daxor Company Profile

(Get Free Report)

Daxor Corporation is a medical diagnostics company focused on providing precise blood volume analysis to support patient management in critical care, surgical, cardiology and nephrology settings. The company’s core offering, the BVA‐100 Blood Volume Analyzer, employs radiolabeled albumin techniques to deliver accurate measurements of total blood volume, red cell mass and plasma volume. By quantifying a patient’s fluid status, Daxor aims to help clinicians tailor therapies for conditions such as anemia, heart failure and fluid overload.

In addition to the BVA‐100 analyzer, Daxor supplies reagent kits, calibration standards and software for data analysis and reporting.